Viz Cardiac Amyloidosis™ One Pager
AI Care Pathway to Support Earlier Clinical Evaluation and Care Coordination
Mar 30, 2026
All Resources
Explore our latest resources
Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care Coordination in...
New AI Care Pathway combines AI echocardiography analysis with coordinated, guideline-based next steps for cardiology and heart failure teams SAN...
Mar 24, 2026
Three New Studies Show Viz.ai’s Cardio Suite Speeds Detection of Cardiac Disease and...
Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed...
Mar 23, 2026
Feb 25, 2026
New Data Show Viz.ai’s AI-Enabled ECG Screening Increases Detection and Accelerates Diagnosis of...
Real-world evidence from the University of Virginia and University of Texas Medical Branch to be presented at American Heart Association...
Nov 04, 2025
Viz.ai Launches Viz ACS™ to Accelerate Treatment for Heart Attack and Reduce Unnecessary...
New solution helps reduce false activations through real-time data sharing and team coordination SAN FRANCISCO – October 8, 2025 –...
Oct 08, 2025
Oct 08, 2025
Viz.ai Announces CMS Reimbursement Pathway for Hypertrophic Cardiomyopathy via AI-Enhanced Electrocardiogram
SAN FRANCISCO – July 29, 2025 - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced...
Jul 29, 2025